Leukotriene B4 and Inflammatory Disease

Overview

Journal Agents Actions

Specialty Pharmacology

Date 1988 Jun 1

PMID 2841828

Citations 18

Authors

R M McMillan

S J Foster

Affiliations

Soon will be listed here.

Abstract

Polymorphonuclear leukocytes (PMNL) are prominent at sites of acute inflammation. Their infiltration is stimulated under pathological conditions by a variety of agents which include bacteria, immune complexes and complement derived chemotactic peptides. Recently attention was focussed on the 5-lipoxygenase product leukotriene B4 (LTB4) which has been demonstrated to induce the key features associated with an acute inflammatory reaction. However, evidence supporting a pro-inflammatory role for LTB4, and therefore the anti-inflammatory efficacy of 5-lipoxygenase inhibitors, is largely circumstantial. Moreover, there are concerns that other chemotactic factors, notably C5a, may compensate for the absence of LTB4. Here we challenge this view and, on the basis of recent experimental and clinical data suggest that LTB4 does not simply duplicate the activity of C5a. Instead we propose that their predominant site(s) of action differ in such a way that they may synergise in mediating PMNL recruitment.

Citing Articles

The ETS domain-containing hematopoietic transcription factor PU.1 mediates the induction of arachidonate 5-lipoxygenase by multi-walled carbon nanotubes in macrophages in vitro.

Lim C, Gu J, Ma Q Arch Toxicol. 2024; 99(2):597-610.

PMID: 39688681 PMC: 11852812. DOI: 10.1007/s00204-024-03925-w.

Multi-walled carbon nanotubes induce arachidonate 5-lipoxygenase expression and enhance the polarization and function of M1 macrophages .

Lim C, Veltri B, Kashon M, Porter D, Ma Q Nanotoxicology. 2023; 17(3):249-269.

PMID: 37115655 PMC: 10263170. DOI: 10.1080/17435390.2023.2204161.

Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping.

Tou K, Cawley A, Bowen C, Bishop D, Fu S Molecules. 2023; 28(1).

PMID: 36615506 PMC: 9822433. DOI: 10.3390/molecules28010312.

Coactosin-like 1 integrates signaling critical for shear-dependent thrombus formation in mouse platelets.

Scheller I, Stritt S, Beck S, Peng B, Pleines I, Heinze K Haematologica. 2019; 105(6):1667-1676.

PMID: 31582545 PMC: 7271572. DOI: 10.3324/haematol.2019.225516.

Identification and characterization of a novel anti-inflammatory lipid isolated from Mycobacterium vaccae, a soil-derived bacterium with immunoregulatory and stress resilience properties.

Smith D, Martinelli R, Besra G, Illarionov P, Szatmari I, Brazda P Psychopharmacology (Berl). 2019; 236(5):1653-1670.

PMID: 31119329 PMC: 6626661. DOI: 10.1007/s00213-019-05253-9.

References

Kreisle R, Parker C, Griffin G, Senior R, Stenson W . Studies of leukotriene B4-specific binding and function in rat polymorphonuclear leukocytes: absence of a chemotactic response. J Immunol. 1985; 134(5):3356-63. View

GOLDMAN D, Goetzl E . Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response. J Exp Med. 1984; 159(4):1027-41. PMC: 2187286. DOI: 10.1084/jem.159.4.1027. View

Aked D, Foster S, Howarth A, McCormick M, Potts H . The inflammatory response of rabbit skin to topical arachidonic acid and its pharmacological modulation. Br J Pharmacol. 1986; 89(2):431-8. PMC: 1917011. DOI: 10.1111/j.1476-5381.1986.tb10277.x. View

Kopp D, Esser B, Tashoff T, GOLDMAN D, Goetzl E, Lemanske Jr R . In vivo and in vitro assessment of the role of leukotriene B4 as a mediator of rat cutaneous late-phase reactions. J Allergy Clin Immunol. 1986; 77(2):302-8. DOI: 10.1016/s0091-6749(86)80108-7. View

Bray M, Ford-Hutchinson A, Smith M . Leukotriene B4: an inflammatory mediator in vivo. Prostaglandins. 1981; 22(2):213-22. DOI: 10.1016/0090-6980(81)90036-8. View

Lewis R, Goetzl E, Drazen J, Soter N, Austen K, Corey E . Functional characterization of synthetic leukotriene B and its stereochemical isomers. J Exp Med. 1981; 154(4):1243-8. PMC: 2186498. DOI: 10.1084/jem.154.4.1243. View

Snyderman R, Goetzl E . Molecular and cellular mechanisms of leukocyte chemotaxis. Science. 1981; 213(4510):830-7. DOI: 10.1126/science.6266014. View

Staub N, Schultz E, Koike K, Albertine K . Effect of neutrophil migration induced by leukotriene B4 on protein permeability in sheep lung. Fed Proc. 1985; 44(1 Pt 1):30-5. View

Goldyne M, Burrish G, Poubelle P, Borgeat P . Arachidonic acid metabolism among human mononuclear leukocytes. Lipoxygenase-related pathways. J Biol Chem. 1984; 259(14):8815-9. View

10.

Shak S, Goldstein I . Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. J Biol Chem. 1984; 259(16):10181-7. View

11.

Wedmore C, Williams T . Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981; 289(5799):646-50. DOI: 10.1038/289646a0. View

12.

GOLDMAN D, Gifford L, Olson D, Goetzl E . Transduction by leukotriene B4 receptors of increases in cytosolic calcium in human polymorphonuclear leukocytes. J Immunol. 1985; 135(1):525-30. View

13.

Lindbom L, Hedqvist P, Dahlen S, Lindgren J, Arfors K . Leukotriene B4 induces extravasation and migration of polymorphonuclear leukocytes in vivo. Acta Physiol Scand. 1982; 116(1):105-8. DOI: 10.1111/j.1748-1716.1982.tb10607.x. View

14.

Aked D, Foster S . Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid. Br J Pharmacol. 1987; 92(3):545-52. PMC: 1853695. DOI: 10.1111/j.1476-5381.1987.tb11355.x. View

15.

Seeger W, Suttorp N, Hellwig A, Bhakdi S . Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. J Immunol. 1986; 137(4):1286-93. View

16.

Movat H, Rettl C, Burrowes C, Johnston M . The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2. Am J Pathol. 1984; 115(2):233-44. PMC: 1900498. View

17.

Williams J, Czop J, Austen K . Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. J Immunol. 1984; 132(6):3034-40. View

18.

Simmons P, Salmon J, Moncada S . The release of leukotriene B4 during experimental inflammation. Biochem Pharmacol. 1983; 32(8):1353-9. DOI: 10.1016/0006-2952(83)90446-x. View

19.

Clancy R, Dahinden C, Hugli T . Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Proc Natl Acad Sci U S A. 1983; 80(23):7200-4. PMC: 390022. DOI: 10.1073/pnas.80.23.7200. View

20.

Forrest M, Jose P, Williams T . Kinetics of the generation and action of chemical mediators in zymosan-induced inflammation of the rabbit peritoneal cavity. Br J Pharmacol. 1986; 89(4):719-30. PMC: 1917228. DOI: 10.1111/j.1476-5381.1986.tb11176.x. View